ID   GTR4_HUMAN              Reviewed;         509 AA.
AC   P14672; Q05BQ3; Q14CX2;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   10-MAY-2017, entry version 200.
DE   RecName: Full=Solute carrier family 2, facilitated glucose transporter member 4;
DE   AltName: Full=Glucose transporter type 4, insulin-responsive;
DE            Short=GLUT-4;
GN   Name=SLC2A4; Synonyms=GLUT4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2656669;
RA   Fukumoto H., Kayano T., Buse J.B., Edwards Y., Pilch P.F., Bell G.I.,
RA   Seino S.;
RT   "Cloning and characterization of the major insulin-responsive glucose
RT   transporter expressed in human skeletal muscle and other insulin-
RT   responsive tissues.";
RL   J. Biol. Chem. 264:7776-7779(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-385.
RX   PubMed=1397719; DOI=10.2337/diab.41.11.1436;
RA   Buse J.B., Yasuda K., Lay T.P., Seo T.S., Olson A.L., Pessin J.E.,
RA   Karam J.H., Seino S., Bell G.I.;
RT   "Human GLUT4/muscle-fat glucose-transporter gene. Characterization and
RT   genetic variation.";
RL   Diabetes 41:1436-1445(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-11.
RX   PubMed=7916714; DOI=10.1016/0378-1119(93)90438-9;
RA   Chiaramonte R., Martini R., Taramelli R., Comi P.;
RT   "Identification of the 5' end of the gene encoding a human insulin-
RT   responsive glucose transporter.";
RL   Gene 130:307-308(1993).
RN   [6]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF 489-LEU-LEU-490.
RX   PubMed=8300557;
RA   Verhey K.J., Birnbaum M.J.;
RT   "A Leu-Leu sequence is essential for COOH-terminal targeting signal of
RT   GLUT4 glucose transporter in fibroblasts.";
RL   J. Biol. Chem. 269:2353-2356(1994).
RN   [7]
RP   INTERACTION WITH DAXX, AND SUMOYLATION.
RX   PubMed=11842083; DOI=10.1074/jbc.M110294200;
RA   Lalioti V.S., Vergarajauregui S., Pulido D., Sandoval I.V.;
RT   "The insulin-sensitive glucose transporter, GLUT4, interacts
RT   physically with Daxx. Two proteins with capacity to bind Ubc9 and
RT   conjugated to SUMO1.";
RL   J. Biol. Chem. 277:19783-19791(2002).
RN   [8]
RP   INTERACTION WITH SRFBP1.
RX   PubMed=16647043; DOI=10.1016/j.bbrc.2006.04.017;
RA   Lisinski I., Matsumoto H., Yver D.R., Schuermann A., Cushman S.W.,
RA   Al-Hasani H.;
RT   "Identification and characterization of p49/STRAP as a novel GLUT4-
RT   binding protein.";
RL   Biochem. Biophys. Res. Commun. 344:1179-1185(2006).
RN   [9]
RP   PHOSPHORYLATION AT SER-274 BY SGK1.
RX   PubMed=17382906; DOI=10.1016/j.bbrc.2007.03.029;
RA   Jeyaraj S., Boehmer C., Lang F., Palmada M.;
RT   "Role of SGK1 kinase in regulating glucose transport via glucose
RT   transporter GLUT4.";
RL   Biochem. Biophys. Res. Commun. 356:629-635(2007).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-57.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [12]
RP   VARIANT NIDDM ILE-383.
RX   PubMed=1918382; DOI=10.1172/JCI115437;
RA   Kusari J., Verma U.S., Buse J.B., Henry R.R., Olefsky J.M.;
RT   "Analysis of the gene sequences of the insulin receptor and the
RT   insulin-sensitive glucose transporter (GLUT-4) in patients with
RT   common-type non-insulin-dependent diabetes mellitus.";
RL   J. Clin. Invest. 88:1323-1330(1991).
RN   [13]
RP   VARIANT NIDDM ILE-383.
RX   PubMed=1756912; DOI=10.2337/diab.40.12.1712;
RA   Choi W.H., O'Rahilly S., Buse J.B., Rees A., Morgan R., Flier J.S.,
RA   Moller D.E.;
RT   "Molecular scanning of insulin-responsive glucose transporter (GLUT4)
RT   gene in NIDDM subjects.";
RL   Diabetes 40:1712-1718(1991).
RN   [14]
RP   VARIANT NIDDM ILE-383.
RX   PubMed=1521731; DOI=10.1007/BF02342449;
RA   O'Rahilly S., Krook A., Morgan R., Rees A., Flier J.S., Moller D.E.;
RT   "Insulin receptor and insulin-responsive glucose transporter (GLUT 4)
RT   mutations and polymorphisms in a Welsh type 2 (non-insulin-dependent)
RT   diabetic population.";
RL   Diabetologia 35:486-489(1992).
CC   -!- FUNCTION: Insulin-regulated facilitative glucose transporter.
CC   -!- SUBUNIT: Interacts with NDUFA9 (By similarity). Binds to DAXX.
CC       Interacts via its N-terminus with SRFBP1. {ECO:0000250,
CC       ECO:0000269|PubMed:11842083, ECO:0000269|PubMed:16647043}.
CC   -!- INTERACTION:
CC       O43889-2:CREB3; NbExp=3; IntAct=EBI-367146, EBI-625022;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}. Endomembrane system
CC       {ECO:0000269|PubMed:8300557}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:8300557}. Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:8300557}. Note=Localizes primarily to the
CC       perinuclear region, undergoing continued recycling to the plasma
CC       membrane where it is rapidly reinternalized. The dileucine
CC       internalization motif is critical for intracellular sequestration.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P14672-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P14672-2; Sequence=VSP_056331, VSP_056332;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Skeletal and cardiac muscles; brown and white
CC       fat.
CC   -!- PTM: Sumoylated. {ECO:0000269|PubMed:11842083}.
CC   -!- DISEASE: Diabetes mellitus, non-insulin-dependent (NIDDM)
CC       [MIM:125853]: A multifactorial disorder of glucose homeostasis
CC       caused by a lack of sensitivity to the body's own insulin.
CC       Affected individuals usually have an obese body habitus and
CC       manifestations of a metabolic syndrome characterized by diabetes,
CC       insulin resistance, hypertension and hypertriglyceridemia. The
CC       disease results in long-term complications that affect the eyes,
CC       kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:1521731,
CC       ECO:0000269|PubMed:1756912, ECO:0000269|PubMed:1918382}. Note=The
CC       disease may be caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- MISCELLANEOUS: Insulin-stimulated phosphorylation of TBC1D4 is
CC       required for GLUT4 translocation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the major facilitator superfamily. Sugar
CC       transporter (TC 2.A.1.1) family. Glucose transporter subfamily.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=GLUT4 entry;
CC       URL="https://en.wikipedia.org/wiki/Glut4";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M20747; AAA59189.1; -; mRNA.
DR   EMBL; M91463; AAA52569.1; -; Genomic_DNA.
DR   EMBL; AC003688; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC034387; AAH34387.1; -; mRNA.
DR   EMBL; BC069615; AAH69615.1; -; mRNA.
DR   EMBL; BC069621; AAH69621.1; -; mRNA.
DR   EMBL; BC113592; AAI13593.1; -; mRNA.
DR   EMBL; BC126164; AAI26165.1; -; mRNA.
DR   EMBL; X58489; CAA41399.1; -; Genomic_DNA.
DR   CCDS; CCDS11097.1; -. [P14672-1]
DR   PIR; A49158; A33801.
DR   RefSeq; NP_001033.1; NM_001042.2. [P14672-1]
DR   UniGene; Hs.380691; -.
DR   ProteinModelPortal; P14672; -.
DR   BioGrid; 112408; 39.
DR   IntAct; P14672; 3.
DR   MINT; MINT-232088; -.
DR   STRING; 9606.ENSP00000320935; -.
DR   ChEMBL; CHEMBL5874; -.
DR   TCDB; 2.A.1.1.80; the major facilitator superfamily (mfs).
DR   iPTMnet; P14672; -.
DR   PhosphoSitePlus; P14672; -.
DR   SwissPalm; P14672; -.
DR   BioMuta; SLC2A4; -.
DR   DMDM; 121761; -.
DR   EPD; P14672; -.
DR   PaxDb; P14672; -.
DR   PeptideAtlas; P14672; -.
DR   PRIDE; P14672; -.
DR   DNASU; 6517; -.
DR   Ensembl; ENST00000317370; ENSP00000320935; ENSG00000181856. [P14672-1]
DR   Ensembl; ENST00000572485; ENSP00000461086; ENSG00000181856. [P14672-2]
DR   GeneID; 6517; -.
DR   KEGG; hsa:6517; -.
DR   UCSC; uc002gfp.4; human. [P14672-1]
DR   CTD; 6517; -.
DR   DisGeNET; 6517; -.
DR   GeneCards; SLC2A4; -.
DR   HGNC; HGNC:11009; SLC2A4.
DR   HPA; CAB016544; -.
DR   MalaCards; SLC2A4; -.
DR   MIM; 125853; phenotype.
DR   MIM; 138190; gene.
DR   neXtProt; NX_P14672; -.
DR   OpenTargets; ENSG00000181856; -.
DR   PharmGKB; PA35879; -.
DR   eggNOG; KOG0569; Eukaryota.
DR   eggNOG; COG0477; LUCA.
DR   GeneTree; ENSGT00760000119022; -.
DR   HOGENOM; HOG000202871; -.
DR   HOVERGEN; HBG014816; -.
DR   InParanoid; P14672; -.
DR   KO; K07191; -.
DR   OMA; SHTHRQP; -.
DR   OrthoDB; EOG091G0A9K; -.
DR   PhylomeDB; P14672; -.
DR   TreeFam; TF313762; -.
DR   Reactome; R-HSA-1445148; Translocation of GLUT4 to the plasma membrane.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   Reactome; R-HSA-428790; Facilitative Na+-independent glucose transporters.
DR   Reactome; R-HSA-70153; Glucose transport.
DR   SIGNOR; P14672; -.
DR   GeneWiki; GLUT4; -.
DR   GenomeRNAi; 6517; -.
DR   PRO; PR:P14672; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000181856; -.
DR   CleanEx; HS_SLC2A4; -.
DR   ExpressionAtlas; P14672; baseline and differential.
DR   Genevisible; P14672; HS.
DR   GO; GO:0005905; C:clathrin-coated pit; IEA:Ensembl.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IDA:UniProtKB.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0012505; C:endomembrane system; ISS:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0070062; C:extracellular exosome; IEA:Ensembl.
DR   GO; GO:0032593; C:insulin-responsive compartment; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0005771; C:multivesicular body; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0030315; C:T-tubule; IEA:Ensembl.
DR   GO; GO:0030140; C:trans-Golgi network transport vesicle; IEA:Ensembl.
DR   GO; GO:0012506; C:vesicle membrane; IDA:MGI.
DR   GO; GO:0055056; F:D-glucose transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0005355; F:glucose transmembrane transporter activity; EXP:Reactome.
DR   GO; GO:0010021; P:amylopectin biosynthetic process; IEA:Ensembl.
DR   GO; GO:0050873; P:brown fat cell differentiation; IEA:Ensembl.
DR   GO; GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEA:Ensembl.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IDA:UniProtKB.
DR   GO; GO:0071470; P:cellular response to osmotic stress; IEA:Ensembl.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl.
DR   GO; GO:0042593; P:glucose homeostasis; IDA:BHF-UCL.
DR   GO; GO:0046323; P:glucose import; NAS:BHF-UCL.
DR   GO; GO:0044381; P:glucose import in response to insulin stimulus; IEA:Ensembl.
DR   GO; GO:0015758; P:glucose transport; TAS:UniProtKB.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   CDD; cd06174; MFS; 1.
DR   InterPro; IPR002441; Glc_transpt_4.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR005828; MFS_sugar_transport-like.
DR   InterPro; IPR003663; Sugar/inositol_transpt.
DR   InterPro; IPR005829; Sugar_transporter_CS.
DR   Pfam; PF00083; Sugar_tr; 1.
DR   PRINTS; PR01193; GLUCTRSPORT4.
DR   PRINTS; PR00171; SUGRTRNSPORT.
DR   SUPFAM; SSF103473; SSF103473; 1.
DR   TIGRFAMs; TIGR00879; SP; 1.
DR   PROSITE; PS50850; MFS; 1.
DR   PROSITE; PS00216; SUGAR_TRANSPORT_1; 1.
DR   PROSITE; PS00217; SUGAR_TRANSPORT_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome; Cytoplasm;
KW   Diabetes mellitus; Disease mutation; Glycoprotein; Membrane;
KW   Phosphoprotein; Polymorphism; Reference proteome; Sugar transport;
KW   Transmembrane; Transmembrane helix; Transport; Ubl conjugation.
FT   CHAIN         1    509       Solute carrier family 2, facilitated
FT                                glucose transporter member 4.
FT                                /FTId=PRO_0000050363.
FT   TOPO_DOM      1     24       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     25     45       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     46     81       Extracellular. {ECO:0000255}.
FT   TRANSMEM     82    102       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    103    111       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    112    132       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    133    142       Extracellular. {ECO:0000255}.
FT   TRANSMEM    143    163       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    164    171       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    172    192       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    193    201       Extracellular. {ECO:0000255}.
FT   TRANSMEM    202    222       Helical; Name=6. {ECO:0000255}.
FT   TOPO_DOM    223    287       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    288    308       Helical; Name=7. {ECO:0000255}.
FT   TOPO_DOM    309    323       Extracellular. {ECO:0000255}.
FT   TRANSMEM    324    344       Helical; Name=8. {ECO:0000255}.
FT   TOPO_DOM    345    353       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    354    374       Helical; Name=9. {ECO:0000255}.
FT   TOPO_DOM    375    384       Extracellular. {ECO:0000255}.
FT   TRANSMEM    385    405       Helical; Name=10. {ECO:0000255}.
FT   TOPO_DOM    406    417       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    418    438       Helical; Name=11. {ECO:0000255}.
FT   TOPO_DOM    439    445       Extracellular. {ECO:0000255}.
FT   TRANSMEM    446    466       Helical; Name=12. {ECO:0000255}.
FT   TOPO_DOM    467    509       Cytoplasmic. {ECO:0000255}.
FT   REGION        7     13       SRFBP1-binding.
FT   REGION      298    304       Monosaccharide binding. {ECO:0000250}.
FT   MOTIF       489    490       Dileucine internalization motif.
FT   BINDING     333    333       Monosaccharide. {ECO:0000250}.
FT   BINDING     404    404       Monosaccharide. {ECO:0000250}.
FT   MOD_RES      10     10       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P19357}.
FT   MOD_RES     274    274       Phosphoserine; by SGK1.
FT                                {ECO:0000269|PubMed:17382906}.
FT   MOD_RES     486    486       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P14142}.
FT   MOD_RES     488    488       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P14142}.
FT   CARBOHYD     57     57       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   VAR_SEQ     342    415       LLVERAGRRTLHLLGLAGMCGCAILMTVALLLLERVPAMSY
FT                                VSIVAIFGFVAFFEIGPGPIPWFIVAELFSQGP -> TAHL
FT                                WNGPSHWLHLPGCPGGVVGGAGGAPDAPSPGPGGHVWLCHP
FT                                DDCGSAPAGASSSHELRLHCGHLWLRGIF (in isoform
FT                                2). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056331.
FT   VAR_SEQ     416    509       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056332.
FT   VARIANT      55     55       S -> R (in dbSNP:rs35198331).
FT                                /FTId=VAR_052503.
FT   VARIANT      78     78       T -> S (in dbSNP:rs5434).
FT                                /FTId=VAR_012060.
FT   VARIANT     358    358       A -> V (in dbSNP:rs8192702).
FT                                /FTId=VAR_020336.
FT   VARIANT     383    383       V -> I (in NIDDM; dbSNP:rs121434581).
FT                                {ECO:0000269|PubMed:1521731,
FT                                ECO:0000269|PubMed:1756912,
FT                                ECO:0000269|PubMed:1918382}.
FT                                /FTId=VAR_007170.
FT   VARIANT     385    385       I -> T (in dbSNP:rs775242206).
FT                                {ECO:0000269|PubMed:1397719}.
FT                                /FTId=VAR_007171.
FT   MUTAGEN     489    490       LL->AA: Changes subcellular location
FT                                mainly to the plasma membrane.
FT                                {ECO:0000269|PubMed:8300557}.
FT   CONFLICT    151    154       Missing (in Ref. 2; AAA52569).
FT                                {ECO:0000305}.
SQ   SEQUENCE   509 AA;  54787 MW;  8E20CD97562C1EBF CRC64;
     MPSGFQQIGS EDGEPPQQRV TGTLVLAVFS AVLGSLQFGY NIGVINAPQK VIEQSYNETW
     LGRQGPEGPS SIPPGTLTTL WALSVAIFSV GGMISSFLIG IISQWLGRKR AMLVNNVLAV
     LGGSLMGLAN AAASYEMLIL GRFLIGAYSG LTSGLVPMYV GEIAPTHLRG ALGTLNQLAI
     VIGILIAQVL GLESLLGTAS LWPLLLGLTV LPALLQLVLL PFCPESPRYL YIIQNLEGPA
     RKSLKRLTGW ADVSGVLAEL KDEKRKLERE RPLSLLQLLG SRTHRQPLII AVVLQLSQQL
     SGINAVFYYS TSIFETAGVG QPAYATIGAG VVNTVFTLVS VLLVERAGRR TLHLLGLAGM
     CGCAILMTVA LLLLERVPAM SYVSIVAIFG FVAFFEIGPG PIPWFIVAEL FSQGPRPAAM
     AVAGFSNWTS NFIIGMGFQY VAEAMGPYVF LLFAVLLLGF FIFTFLRVPE TRGRTFDQIS
     AAFHRTPSLL EQEVKPSTEL EYLGPDEND
//
